<DOC>
	<DOCNO>NCT00976716</DOCNO>
	<brief_summary>To investigate efficacy , safety tolerability Celecoxib patient posttraumatic pain duration 8 day .</brief_summary>
	<brief_title>An Open-Label Study Of Celecoxib In Patients With Posttraumatic Pain</brief_title>
	<detailed_description />
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Patients posttraumatic pain able control oral NSAID Patients `` pain '' meet follow criterion within 48 hour injury : `` Pain '' Pain intensity ( Categorical ) : `` Moderate pain '' `` Severe pain '' Pain intensity ( VAS ) : 45.0 mm Patients `` inflammation '' meet follow criterion within 48 hour injury . `` Inflammation '' Categorical : `` Mild '' , `` Moderate '' `` Severe '' Patients receive analgesic anaesthetic injury Patients history/complication aspirininduced asthma Patients take excluded medication Patients history/complication ischaemic heart disease , serious cardiac arrhythmia , cardiac failure congestive cerebrovascular disorder history/plan revascularization</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>posttraumatic pain</keyword>
</DOC>